By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Foamix Pharmaceuticals, Ltd. 

2 Holzman Street
Weizmann-Science Park
Rehovot    76704  Israel
Phone: 972-8-9316233 Fax: n/a



Company News
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Initiation Of Phase 2 Trial With FDX104 In Chemotherapy Induced Rash 10/6/2014 7:20:47 AM
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Closing Of Initial Public Offering 9/24/2014 7:17:34 AM
Foamix Pharmaceuticals, Ltd. (FOMX) Prices IPO At $6 A Share 9/18/2014 10:29:30 AM
Israeli Biotech Foamix Files For A $75 Million IPO 8/14/2014 11:16:15 AM
Foamix To Present At The 2014 Biotechnology Industry Organization (BIO) International Convention On June 26th In San Diego 6/18/2014 9:16:41 AM
Foamix Establishes U.S. Subsidiary And Strengthens Executive Management With Appointment Of Senior U.S. Leadership Team 6/12/2014 7:23:18 AM
Foamix Announces Collaboration With National Institutes of Health (NIH) 6/3/2014 9:22:00 AM
Foamix Announces The Issuance Of Five Additional U.S. Patents 4/21/2014 9:17:18 AM
Foamix To Present At The 34th Annual Cowen and Company Health Care Conference -- Successful Phase 2 For First Ever Topical Minocycline For Acne And Impetigo 2/27/2014 9:15:05 AM
Merz North America and Foamix to Develop an Innovative Medicated Foam 7/8/2013 10:21:50 AM